Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

15 Thailand General Pharmaceuticals Reports

Asia Pacific DPP Drugs Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: AstraZeneca, Eli Lilly and Company, Merck, Novartis, Bristol-Myers Squibb

Asia-Pacific Alpha-Glucosidase Inhibitors Industry

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Takeda Pharmaceuticals, Pfizer, Bayer, Sun Pharmaceuticals Industries, Glenmark Pharmaceuticals

Asia Pacific SGLT2 Inhibitors Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb

APAC Biguanide Industry

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi

Asia-Pacific GLP 1 Agonist Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk, Sanofi, Biocon

APAC Insulin Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee

APAC Meglitinide Industry

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon

Alpha Glucosidase Inhibitor Drugs Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer

Meglitinides Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk

DPP4 Drugs Industry

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Eli Lilly and Company

Glargine Insulin Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Sanofi, Novo Nordisk, Biocon, Eli Lilly and Company, Julphar

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Wockhardt

GLP-1 Agonists Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk, Pfizer

Sulfonylureas Industry

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories

Biguanides Market

Country Covered: Thailand

Study Period: 2019 - 2030

Major Players: Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Sanofi, Merck